Literature DB >> 2600191

Bayesian forecasting of APTT response to continuously infused heparin with and without warfarin administration.

D Mungall1, R Floyd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600191     DOI: 10.1002/j.1552-4604.1989.tb03276.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  6 in total

1.  Anticoagulation therapy advisor: a decision-support system for heparin therapy during ECMO.

Authors:  R L Peverini; M Sale; W D Rhine; L M Fagan; L A Lenert
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1992

Review 2.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 3.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

4.  Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins.

Authors:  Hesham S Al-Sallami; Michael A Barras; Bruce Green; Stephen B Duffull
Journal:  Clin Pharmacokinet       Date:  2010-09       Impact factor: 6.447

5.  New method to predict patients' intravenous heparin dose requirements.

Authors:  B M Reilly; R A Raschke
Journal:  J Gen Intern Med       Date:  1996-03       Impact factor: 5.128

Review 6.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.